Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06155682 · ClinicalTrials.gov registry record · NA

TMS for Inhibition Enhancement in Schizophrenia

A NA study of Schizophrenia, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT06155682 is a NA study of Schizophrenia that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06155682, a NA study of Schizophrenia, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This study purpose is to perform a pilot mechanistic trial repetitive transcranial magnetic stimulation (rTMS) clinical trial in 34 people with schizophrenia (Sz). The trial will evaluate whether inhibitory 1 Hertz (Hz) rTMS targeting motor cortex can increase brain inhibition reflected in a decrease in the short-interval intracortical inhibition (SICI) score from pre-to-post-treatment. We will also collect preliminary data on the effect of rTMS on the resting functional connectivity of the motor cortex and other brain regions and the relationship of change in SICI to change in cognitive performance

Conditions Studied

Interventions

  • DEVICE repetitive transcranial magnetic stimulation (active)
  • DEVICE repetitive transcranial magnetic stimulation (sham)

Study Locations (1)

Maryland

  • Maryland Psychiatric Research Center - Catonsville

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2026-02-02
Est. Completion 2029-04
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT06155682

The ClinicalTrials.gov registry entry for NCT06155682 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (84% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which repetitive transcranial magnetic stimulation (active) is the first listed.

NCT06155682 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06155682 about?

NCT06155682 is a clinical study titled "TMS for Inhibition Enhancement in Schizophrenia". This study purpose is to perform a pilot mechanistic trial repetitive transcranial magnetic stimulation (rTMS) clinical trial in 34 people with schizophrenia (Sz). The trial will evaluate whether inhibitory 1 Hertz (Hz) rTMS targeting motor cortex can increase brain inhibition reflected in a decreas...

What is the current status of trial NCT06155682?

This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-02-02. Estimated completion is 2029-04.

What conditions does trial NCT06155682 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT06155682?

The interventions under investigation include: repetitive transcranial magnetic stimulation (active) (DEVICE), repetitive transcranial magnetic stimulation (sham) (DEVICE).

Who is sponsoring clinical trial NCT06155682?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06155682 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.